India
· Delayed Price · Currency is INR Balaxi Pharmaceuticals Statistics
Total Valuation
NSE:BALAXI has a market cap or net worth of INR 3.60 billion. The enterprise value is 3.31 billion.
| Market Cap | 3.60B |
| Enterprise Value | 3.31B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:BALAXI has 50.91 million shares outstanding. The number of shares has increased by 7.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.91M |
| Shares Change (YoY) | +7.02% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 4.93% |
| Owned by Institutions (%) | 9.33% |
| Float | 8.26M |
Valuation Ratios
The trailing PE ratio is 14.08.
| PE Ratio | 14.08 |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.09 |
| EV / Sales | 1.20 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 9.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | n/a |
| Interest Coverage | 12.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.67% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.60M |
| Profits Per Employee | 456,107 |
| Employee Count | 600 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.28% in the last 52 weeks. The beta is 0.59, so NSE:BALAXI's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -31.28% |
| 50-Day Moving Average | 66.80 |
| 200-Day Moving Average | 93.07 |
| Relative Strength Index (RSI) | 64.23 |
| Average Volume (20 Days) | 547,390 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BALAXI had revenue of INR 2.76 billion and earned 273.66 million in profits. Earnings per share was 5.02.
| Revenue | 2.76B |
| Gross Profit | 1.21B |
| Operating Income | 360.36M |
| Pretax Income | 305.01M |
| Net Income | 273.66M |
| EBITDA | 380.70M |
| EBIT | 360.36M |
| Earnings Per Share (EPS) | 5.02 |
Balance Sheet
The company has 608.67 million in cash and 321.02 million in debt, giving a net cash position of 287.65 million or 5.65 per share.
| Cash & Cash Equivalents | 608.67M |
| Total Debt | 321.02M |
| Net Cash | 287.65M |
| Net Cash Per Share | 5.65 |
| Equity (Book Value) | 2.16B |
| Book Value Per Share | 39.51 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 43.78%, with operating and profit margins of 13.05% and 9.91%.
| Gross Margin | 43.78% |
| Operating Margin | 13.05% |
| Pretax Margin | 11.05% |
| Profit Margin | 9.91% |
| EBITDA Margin | 13.79% |
| EBIT Margin | 13.05% |
| FCF Margin | n/a |
Dividends & Yields
NSE:BALAXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.02% |
| Shareholder Yield | -7.02% |
| Earnings Yield | 7.61% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.
| Last Split Date | May 30, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |